Literature DB >> 2541535

Characterization of N- and O-linked oligosaccharides of glycoprotein 350 from Epstein-Barr virus.

F Serafini-Cessi1, N Malagolini, M Nanni, F Dall'Olio, G Campadelli-Fiume, J Tanner, E Kieff.   

Abstract

Glycoprotein 350 (gp350), the major Epstein-Barr Virus (EBV) envelope glycoprotein, has extensive N- and O-linked oligosaccharide chains. To characterize these oligosaccharide chains, [3H]glucosamine-labeled gp350 was isolated from an EBV transformed marmoset lymphoblastoid cell line (B95-8) induced to replicate EBV. Radiolabeled pronase-glycopeptides were fractionated by serial affinity chromatography and O-linked oligosaccharides released by mild alkaline borohydride treatment. Virtually all (99%) N-linked oligosaccharides were of complex type, with a predominance of tri-tetraantennary versus diantennary chains. A significant portion (28%, in term of radioactivity) of the tri-tetraantennary chains bound to leucoagglutinin-agarose, indicating an additional branch in beta(1-6)-linkage to the trimannosyl core. N-linked oligosaccharides with such a branching pattern have not been previously described in any herpesvirus glycoprotein, but have been associated with neoplastic transformation. Half of [3H]glucosamine incorporated into gp350 was recovered in O-linked oligosaccharides. The smallest chains have a core beta Gal-GalNAc disaccharide structure. Most O-linked chains have two to three N-acetylglucosamine and one N-acetylgalactosamine residues, besides the N-acetylgalactosamine residue located at the terminal reducing end, suggesting a di- or tri- N-acetyllactosamine structure. Consistent with such a structure, the size of these chains, after sialic acid removal, was that of an heptasaccharide or larger.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2541535     DOI: 10.1016/0042-6822(89)90345-0

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  12 in total

Review 1.  Control of viral disease: the development of Epstein-Barr virus vaccines.

Authors:  A J Morgan
Journal:  Springer Semin Immunopathol       Date:  1991

2.  Identification of upstream promoter elements mediating early transcription from the 35,000-molecular-weight protein gene of Autographa californica nuclear polyhedrosis virus.

Authors:  J A Dickson; P D Friesen
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

3.  Role of the TSG101 gene in Epstein-Barr virus late gene transcription.

Authors:  Huey-Huey Chua; Heng-Huan Lee; Shih-Shin Chang; Chih-Chung Lu; Te-Huei Yeh; Tsuey-Ying Hsu; Tzu-Hao Cheng; Jiin-Tsuey Cheng; Mei-Ru Chen; Ching-Hwa Tsai
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

4.  Intracellular trafficking of two major Epstein-Barr virus glycoproteins, gp350/220 and gp110.

Authors:  M Gong; E Kieff
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

5.  The apoptotic suppressor P35 is required early during baculovirus replication and is targeted to the cytosol of infected cells.

Authors:  P A Hershberger; D J LaCount; P D Friesen
Journal:  J Virol       Date:  1994-06       Impact factor: 5.103

6.  Epstein-Barr viruses that express a CD21 antibody provide evidence that gp350's functions extend beyond B-cell surface binding.

Authors:  Clemens Busse; Regina Feederle; Martina Schnölzer; Uta Behrends; Josef Mautner; Henri-Jacques Delecluse
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

7.  Global Mapping of O-Glycosylation of Varicella Zoster Virus, Human Cytomegalovirus, and Epstein-Barr Virus.

Authors:  Ieva Bagdonaite; Rickard Nordén; Hiren J Joshi; Sarah L King; Sergey Y Vakhrushev; Sigvard Olofsson; Hans H Wandall
Journal:  J Biol Chem       Date:  2016-04-15       Impact factor: 5.157

8.  Marburg virus gene 4 encodes the virion membrane protein, a type I transmembrane glycoprotein.

Authors:  C Will; E Mühlberger; D Linder; W Slenczka; H D Klenk; H Feldmann
Journal:  J Virol       Date:  1993-03       Impact factor: 5.103

9.  The CAGT motif functions as an initiator element during early transcription of the baculovirus transregulator ie-1.

Authors:  S S Pullen; P D Friesen
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

10.  The bovine herpesvirus 4 Bo10 gene encodes a nonessential viral envelope protein that regulates viral tropism through both positive and negative effects.

Authors:  Bénédicte Machiels; Céline Lété; Katalin de Fays; Jan Mast; Benjamin Dewals; Philip G Stevenson; Alain Vanderplasschen; Laurent Gillet
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.